CAPRIN1 (Cell Cycle Associated Protein 1) encodes an RNA-binding protein that plays critical roles in stress granule formation, mRNA transport, and translational regulation. CAPRIN1 is implicated in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and potentially Alzheimer's disease through its involvement in RNA metabolism and protein aggregation dynamics.
| Attribute |
Value |
| Gene Symbol |
CAPRIN1 |
| Full Name |
Cell Cycle Associated Protein 1 |
| Alternative Names |
RNG105, Hu-PRLP |
| Chromosomal Location |
11p13 |
| NCBI Gene ID |
9908 |
| Ensembl ID |
ENSG00000135387 |
| UniProt ID |
Q14444 |
| OMIM |
608157 |
| Protein Class |
RNA-binding protein |
| Associated Diseases |
ALS, FTD, Alzheimer's disease |
The CAPRIN1 gene spans approximately 35 kb and consists of 17 exons. It encodes a protein of approximately 709 amino acids.
CAPRIN1 contains several functional domains:
- RNA recognition motifs (RRMs) — Bind to specific RNA sequences
- RG-rich region — Mediates protein-protein interactions
- Nuclear localization signal — Enables nuclear-cytoplasmic shuttling
- Prion-like domains — Enable phase separation and granule formation
CAPRIN1 is a key node in stress granule assembly:
- Stress response — Formed in response to cellular stress (oxidative, heat, viral)
- mRNA sequestration — Stores translationally stalled mRNAs
- Translation control — Temporarily silences non-essential translation
- Recovery — Disassembly allows translation restart after stress
CAPRIN1 facilitates mRNA transport in neurons:
- Dendritic localization — Transports mRNAs to dendritic compartments
- Synaptic plasticity — Enables local protein synthesis at synapses
- Axonal transport — Carries mRNAs for local translation
- Neuronal function — Supports activity-dependent protein synthesis
CAPRIN1 modulates translation:
- Translation initiation — Interacts with translation initiation factors
- Ribosome recruitment — Facilitates mRNA loading onto ribosomes
- Polysome regulation — Controls polysome assembly and disassembly
- Feedback control — Links translation to cellular stress
CAPRIN1 is expressed in various brain regions:
- Cerebral cortex — Pyramidal neurons
- Hippocampus — CA1-CA3 pyramidal cells, dentate gyrus
- Cerebellum — Purkinje cells
- Spinal cord — Motor neurons (particularly vulnerable in ALS)
- Brainstem — Various nuclei
High expression in motor neurons explains vulnerability in ALS.
CAPRIN1 activity is regulated through:
- Phosphorylation — Affects granule assembly dynamics
- Cellular stress — Post-translational modifications in response to stress
- Alternative splicing — Generates different isoforms
- Neuronal activity — Activity-dependent regulation
CAPRIN1 is strongly implicated in ALS:
- Stress granule persistence — Mutations affect granule dynamics
- Protein aggregation — Links to TDP-43 pathology
- Motor neuron vulnerability — High expression in vulnerable neurons
- Genetic variants — Associated with ALS risk
CAPRIN1 connects to FTD:
- TDP-43 pathology — Shares mechanisms with ALS
- Stress granule dysfunction — Common molecular link
- RNA metabolism — Disrupted in FTD brain
- Co-occurrence — ALS-FTD spectrum disorders
Potential role in AD:
- mRNA dysregulation — Altered translation in AD brain
- Stress response — Impaired stress granule function
- Synaptic plasticity — Affects synaptic protein synthesis
- Protein aggregation — Links to amyloid and tau pathology
CAPRIN1-mediated granule formation involves:
- Stress detection — Cellular stress triggers signaling cascades
- Phase separation — CAPRIN1 undergoes liquid-liquid phase separation
- mRNA recruitment — Specific mRNAs are sequestered
- Granule maturation — Dynamic exchange of components
- Disassembly — After stress resolution, granules dissolve
CAPRIN1 affects RNA metabolism through:
- Pre-mRNA processing — Alternative splicing regulation
- mRNA stability — Controls mRNA half-life
- Translation efficiency — Modulates protein synthesis
- Quality control — Targets aberrant RNAs for degradation
CAPRIN1 interacts with several disease-related proteins:
- TDP-43 — Major protein in ALS/FTD inclusions
- FUS — Another ALS-associated RNA-binding protein
- G3BP1 — Stress granule marker protein
- TIA1 — Stress granule component
- No direct CAPRIN1-targeted therapies
- Symptomatic management of ALS/FTD
- Supportive care for patients
- Stress granule modulators — Normalize granule dynamics
- RNA-based therapeutics — Target disease-associated RNAs
- Protein aggregation inhibitors — Prevent toxic aggregation
- Neuroprotective agents — Support motor neuron survival
- Small molecule inhibitors — Target CAPRIN1-protein interactions
- Antisense oligonucleotides — Modulate CAPRIN1 expression
Key experimental approaches for studying CAPRIN1 include:
- Live-cell imaging: Visualizing stress granule dynamics in real-time
- FRAP: Measuring granule流动性
- Proteomics: Identifying CAPRIN1 interaction partners
- RNA-seq: Profiling CAPRIN1-regulated mRNAs
- iPSC models: Patient-derived neurons for disease modeling
- CRISPR screens: Identifying modifiers of stress granule behavior
Several animal models illuminate CAPRIN1 function:
- CAPRIN1 knockout mice: Embryonic lethal, neural tube defects
- Conditional knockout: Motor neuron degeneration phenotype
- Transgenic models: Human CAPRIN1 expression in mouse brain
- Zebra fish models: In vivo visualization of granule dynamics
Stress granule function declines with age:
- Granule clearance slowdown: Impaired disassembly mechanisms
- Protein quality control: Reduced autophagy of granules
- mRNA decay: Altered mRNA stability in aging neurons
- Translation regulation: Dysregulated protein synthesis
These age-related changes may contribute to neurodegeneration susceptibility.
CAPRIN1 undergoes liquid-liquid phase separation (LLPS):
- Low-complexity domains: Enable multivalent interactions
- Molecular triggers: Stress signals promote LLPS
- Material properties: Transition from liquid to gel states
- Disease implications: Aberrant phase transitions in neurodegeneration
CAPRIN1 forms complexes with multiple disease-relevant proteins:
| Protein |
Nature of Interaction |
| TDP-43 |
Co-localization in stress granules, co-aggregation |
| FUS |
RNA-binding partner, co-trafficking |
| G3BP1 |
Core stress granule component |
| TIA1 |
Granule scaffolding protein |
| hnRNPA1 |
Alternative splicing regulation |
| OPTN |
Autophagy receptor for granule clearance |
CAPRIN1 has potential as a biomarker:
- Cerebrospinal fluid: CAPRIN1 levels in CSF
- Blood samples: Peripheral blood mononuclear cell expression
- Imaging biomarkers: PET ligands targeting stress granules (under development)
Research priorities include:
- Understanding CAPRIN1's specific mRNA targets in neurons
- Determining how CAPRIN1 mutations cause ALS/FTD
- Developing therapies targeting stress granule dynamics
- Creating better cellular and animal models
- Identifying biomarkers for early detection
CAPRIN1 is an RNA-binding protein that plays critical roles in stress granule formation, mRNA transport, and translational regulation in neurons. Its involvement in amyotrophic lateral sclerosis, frontotemporal dementia, and potentially Alzheimer's disease makes it an important subject of neurodegenerative disease research. The protein's function in stress granule dynamics, local translation at synapses, and interaction with TDP-43 and other disease proteins provides mechanistic insights into neurodegeneration. Understanding CAPRIN1 biology offers opportunities for developing novel therapeutic approaches targeting RNA metabolism dysfunction in these devastating diseases.
The convergence of multiple RNA-binding proteins (TDP-43, FUS, TIA1, G3BP1, and CAPRIN1) in stress granules suggests that dysregulated RNA granule biology is a central mechanism in ALS/FTD pathogenesis. Future research should focus on understanding the precise molecular interactions within these granules and developing interventions that restore proper granule dynamics without disrupting essential cellular functions.